3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
24
Observational
1
Expanded_access
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Urogenital Neoplasms
1
Urinary Bladder Neoplasms
1
Carcinoma, Transitional Cell
1
Carcinoma, Renal Cell
1
Interventions
atezolizumab
5
avelumab
4
erdafitinib
1
enfortumab vedotin
1
darolutamide
1
Therapeutics
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Radiotherapy
1
Patient Reported Outcome Measures
1
Nivolumab
1
Mitomycin
1
Magnetic Resonance Spectroscopy
1
Laparoscopy
1
Immunotherapy
1
Histocompatibility Testing
1
High-Throughput Nucleotide Sequencing
1
Hematologic Tests
1
Gemcitabine
1
Focus Groups
1
Educational Status
1
Drug Therapy
1
Defecation
1
Cytological Techniques
1
Cystoscopy
1
Cisplatin
1
Carboxylesterase
1
Blood Cell Count
1
Biomarkers
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Carcinoma, Transitional Cell
×
enfortumab vedotin
×
Clear all
NCT06724159
2026-02-17
SOGUG-PRINCIS
Spanish Oncology Genito-Urinary Group
Recruiting
500 enrolled